Concepedia

Vladimir Semiglazov

VS

Statistics

Publications

9

Citations

648

H-Index

9

Active since

2004

Affiliations

Institute of Oncology NN Petrov(Current)

European Institute of Oncology

Agaplesion Markus Hospital

Hospital Universitario Miguel Servet

Paracelsus Medical University

Vladimir Semiglazov is an author at Institute of Oncology NN Petrov specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2004–2023

9

Publications

9

Spatial predictors of immunotherapy response in triple-negative breast cancer

Xiao Qian Wang, Esther Danenberg, Chiun‐Sheng Huang et al. · Nature · 2023 · 325 citations · Full text

Medicine, Immunology, Oncology +17

Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy

Kimberly Blackwell, Vladimir Semiglazov, Dmitriy Krasnozhon et al. · Annals of Oncology · 2015 · 81 citations · Full text

Medicine, Oncology, Pharmacology +16

European Cooperative Trial in Operable Breast Cancer (ECTO): Improved freedom from progression (FFP) from adding paclitaxel (T) to doxorubicin (A) followed by cyclophosphamide methotrexate and fluorouracil (CMF)

Lorenzo Gianni, J. Baselga, W. Eiermann et al. · Journal of Clinical Oncology · 2005 · 66 citations

Medicine, Oncology, Pharmacology +17

LBA13 Tumour infiltrating lymphocytes (TILs), PD-L1 expression and their dynamics in the NeoTRIPaPDL1 trial

Giampaolo Bianchini, Chiun‐Sheng Huang, Daniel Egle et al. · Annals of Oncology · 2020 · 51 citations

Medicine, Immunology, Oncology +14

RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer

Vladimir Semiglazov · JNCI Monographs · 2015 · 42 citations · Full text

Medicine, Oncology, Radiology +17

1–5 of 9